Nanoparticle Albumin-bound Paclitaxel (NabP) As A Single Agent For The Treatment Of Recurrent Stage 4 Non-small Cell Lung Cancer (NSCLC).

被引：0
|
作者：
Saxena, A. [1 ]
Christos, P. J. [1 ]
Cagney, J. M. [1 ]
Scheff, R. J. [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S310 / S311
页数：2
相关论文
共 50 条
  • [1] Retrospective analysis of nanoparticle albumin-bound paclitaxel (nabP) administered as a single agent in the treatment of recurrent stage IV (st4) non-small cell lung cancer (NSCLC).
    Saxena, Ashish
    Christos, Paul J.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Ashish Saxena
    Bryan J. Schneider
    Paul J. Christos
    Lauren F. Audibert
    Jennifer M. Cagney
    Ronald J. Scheff
    [J]. Medical Oncology, 2016, 33
  • [3] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Saxena, Ashish
    Schneider, Bryan J.
    Christos, Paul J.
    Audibert, Lauren F.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    [J]. MEDICAL ONCOLOGY, 2016, 33 (02) : 1 - 9
  • [4] Adjuvant Chemotherapy with Nanoparticle Albumin-Bound Paclitaxel and Carboplatin for Stage IB Non-small Cell Lung Cancer
    Motooka, Y.
    Matsuishi, K.
    Maruyama, R.
    Yoshimoto, K.
    Sakata, S.
    Aoki, M.
    Marutsuka, T.
    Tanaka, F.
    Suetsugu, T.
    Suzuki, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S528 - S529
  • [5] Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Blair, Hannah A.
    Deeks, Emma D.
    [J]. DRUGS, 2015, 75 (17) : 2017 - 2024
  • [6] Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Hannah A. Blair
    Emma D. Deeks
    [J]. Drugs, 2015, 75 : 2017 - 2024
  • [7] THE ROLE OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL (NAB-P) IN THE NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS
    Kavvadias, Alexandros
    Charpidou, Andriani G.
    Gkiozos, Ioannis
    Syrigos, Kostas N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1256 - S1257
  • [8] The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease
    Yasuda, Yuichiro
    Hattori, Yoshihiro
    Tohnai, Rie
    Ito, Shoichi
    Kawa, Yoshitaka
    Kono, Yuko
    Urata, Yoshiko
    Nogami, Munenobu
    Takenaka, Daisuke
    Negoro, Shunichi
    Satouchi, Miyako
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (01) : 89 - 93
  • [9] A Retrospective Analysis Of Nanoparticle Albumin Bound Paclitaxel In Chinese Patients With Recurrent Advanced Non-small Cell Lung Cancer In A Single Center
    Zhu, Yixiang
    Xing, Puyuan
    Chen, Sipeng
    Li, Junling
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S899 - S900
  • [10] Efficacy and safety of nanoparticle albumin-bound paclitaxel in non-small cell lung cancer: a systematic review and meta-analysis
    Tan, Hong
    Hu, Jing
    Liu, Shan
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 268 - 277
12345